Quicklists
public 01:14:47

Jean Clairambault : Drug resistance in cancer: biological and medical issues, and continuous models of structured population dynamics

  -   Mathematical Biology ( 120 Views )

Considering cancer as an evolutionary disease, we aim at understanding the means by which cancer cell populations develop resistance mechanisms to drug therapies, in order to circumvent them by using optimised therapeutic combinations. Rather than focusing on molecular mechanisms such as overexpression of intracellular drug processing enzymes or ABC transporters that are responsible for resistance at the individual cell level, we propose to introduce abstract phenotypes of resistance structuring cancer cell populations. The models we propose rely on continuous adaptive dynamics of cell populations, and are amenable to predict asymptotic evolution of these populations with respect to the phenotypic traits of interest. Drug-induced drug resistance, the question we are tackling from a theoretical and experimental point of view, may be due to biological mechanisms of different natures, mere local regulation, epigenetic modifications (reversible, nevertheless inheritable) or genetic mutations (irreversible), according to the extent to which the genome of the cells in the population is affected. In this respect, the models we develop are more likely to be biologically corresponding to epigenetic modifications, although eventual induction of emergent resistant cell clones due to mutations under drug pressure is not to be completely excluded. From the biologist's point of view, we study phenotypically heterogeneous, but genetically homogeneous, cancer cell populations under stress by drugs. According to the cell populations at stake and to the exerted drug pressure, is drug resistance in cancer a permanently acquired phenotypic trait or is it reversible? Can it be avoided or overcome by rationally (model-guided) designed combinations of drugs? These are some of the questions we will try to answer in a collaboration between a team of mathematicians and another one of biologists, both dealing with cancer and Darwinian - possibly also Lamarckian - evolution of cell populations.

public 01:29:52

Anita Layton : Myogenic Response to Systolic Pressure in the Afferent Arteriole

  -   Mathematical Biology ( 120 Views )

Elevations in systolic blood pressure are believed to be closely linked to the pathogenesis and progression of renal diseases. It has been hypothesized that the afferent arteriole (AA) protects the glomerulus from the damaging effects of hypertension by sensing increases in systolic blood pressure and responding with a compensatory vasoconstriction. To investigate this hypothesis, we developed a mathematical model of the myogenic response of an AA smooth muscle cell, based on an arteriole model by Gonzalez-Fernandez and Ermentrout (Math Biosci 1994). renal hemodynamic regulation. The model incorporates ionic transport, cell membrane potential, contraction of the AA smooth muscle cell, and the mechanics of a thick-walled cylinder. The model represents a myogenic response based on a pressure-induced shift in the voltage dependence of calcium channel openings: with increasing transmural pressure, model vessel diameter decreases; and with decreasing pressure, vessel diameter increases. Further, the model myogenic mechanism includes a rate-sensitive component that yields constriction and dilation kinetics similar to behaviors observed in vitro. A parameter set is identified based on physical dimensions of an AA in a rat kidney. Model results suggest that the interaction of Ca2+ and K+ fluxes mediated by voltage-gated and voltage-calcium-gated channels, respectively, gives rise to periodicity in the transport of the two ions. This results in a time-periodic cytoplasmic calcium concentration, myosin light chains phosphorylation, and crossbridges formation with the attending muscle stress. Further, the model predicts myogenic responses that agree with experimental observations, most notably those which demonstrate that the renal AA constricts in response to increases in both steady and systolic blood pressures. The myogenic model captures these essential functions of the renal AA, and it may prove useful as a fundamental component in a multi-scale model of the renal microvasculature suitable for investigations of the pathogenesis of hypertensive renal diseases.